Orbis Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Orbis Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11197
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Orbis Biosciences Inc (Orbis) is a developer of pharmaceutical products that offers optimizes oral and injectable products. The company provides preclnical pipeline indications for pathologies including cancer, bronchiolitis, Eczema, atopic dermatitis, nephrotic syndrome, HIV, asthma, buninectomy, head and neck cancers, steroid responsive inner ear conditions, chest congestion, hemorrphoidectomy; and for post-surgical pain management, contraceptives, and animal health. It develops novel controlled-release delivery system. Orbis creates oral and injectable therapeutics to improve compliance and patient satisfaction. The company products address clinical needs and are at various stages of development. The company caters pharmaceuticals, consumer products, foods and beverages and chemical industries. Orbis is headquartered in Lenexa, Kansas, the US.

Orbis Biosciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Orbis Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Orbis Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Dare Bioscience Enters into Development and Option Agreement with Orbis Biosciences 11
FHI 360 Enters into Co-Development Agreement with Orbis Biosciences 12
Debt Offering 13
Orbis Biosciences Raises USD0.99 Million in Debt Offering 13
Orbis Biosciences Inc – Key Competitors 14
Orbis Biosciences Inc – Key Employees 15
Orbis Biosciences Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Orbis Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Orbis Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Orbis Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Dare Bioscience Enters into Development and Option Agreement with Orbis Biosciences 11
FHI 360 Enters into Co-Development Agreement with Orbis Biosciences 12
Orbis Biosciences Raises USD0.99 Million in Debt Offering 13
Orbis Biosciences Inc, Key Competitors 14
Orbis Biosciences Inc, Key Employees 15

List of Figures
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Orbis Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Orbis Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Orbis Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Viridian Energy Supply Ltd:企業の戦略的SWOT分析
    Viridian Energy Supply Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Mega Corporation Ltd
    Mega Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Mega Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Clark Public Utilities:企業の戦略的SWOT分析
    Clark Public Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Phibro Animal Health Corp (PAHC):企業の財務・戦略的SWOT分析
    Phibro Animal Health Corp (PAHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Genesee BioMedical Inc-医療機器分野:企業M&A・提携分析
    Summary Genesee BioMedical Inc (Genesee BioMedical) is a medical device company that provides medical and surgical instruments. The company’s products include coronary bypass graft markers, pediatric and adult cardiac surgical instruments, off-pump CABG devices, adult thoracic retractors, and cardia …
  • Sartorius AG (SRT):製薬・医療:M&Aディール及び事業提携情報
    Summary Sartorius AG (Sartorius) manufactures and distributes laboratory and process technology equipment. The company’s lab products portfolio includes laboratory instruments, such as pipettes, laboratory water purification systems, weight sets and lab balances. It provides bioprocess solutions for …
  • IAC/INTERACTIVECORP:企業の戦略・SWOT・財務分析
    IAC/INTERACTIVECORP - Strategy, SWOT and Corporate Finance Report Summary IAC/INTERACTIVECORP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Albireo Pharma Inc (ALBO):製薬・医療:M&Aディール及び事業提携情報
    Summary Albireo Pharma Inc (Albireo), formerly Biodel Inc., focuses on the development and commercialization of innovative bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal (GI) disorders and diseases where inappropriate flow of bile causes severe med …
  • Amicus Therapeutics Inc (FOLD):企業の財務・戦略的SWOT分析
    Amicus Therapeutics Inc (FOLD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • LifeAssays AB (LIFE B)-医療機器分野:企業M&A・提携分析
    Summary LifeAssays AB (LifeAssays) is a medical device company that develops, manufactures and markets in-vitro diagnostic and veterinary care products. The company provides point-of-care diagnostic testing systems. Its product portfolio includes lifeassays human system and lifeassays veterinary sys …
  • NOF Corp (4403):企業の財務・戦略的SWOT分析
    NOF Corp (4403) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Time Inc.:企業のM&A・事業提携・投資動向
    Time Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Time Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Obton AS-エネルギー分野:企業M&A・提携分析
    Summary Obton A/S (Obton) is an investment company that specializes in management of assets within renewable energy. The company's investment process include screening process which inludes verification of prerequisites such as financial terms, amount of irradiation, power purchase agreement and fee …
  • Havas SA:企業の戦略的SWOT分析
    Havas SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • ElectraNet Pty Ltd:企業の戦略的SWOT分析
    ElectraNet Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Jungheinrich AG:企業の戦略・SWOT・財務情報
    Jungheinrich AG - Strategy, SWOT and Corporate Finance Report Summary Jungheinrich AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Entreprise Tunisienne d’Activites Petrolieres:企業の戦略的SWOT分析
    Entreprise Tunisienne d'Activites Petrolieres - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Natcore Technology Inc (NXT):企業の財務・戦略的SWOT分析
    Summary Natcore Technology Inc (Natcore) is a solar research and development company that provides products for semiconductor and fiber optic applications. The company’s products include solar cell structures and black silicon cells. It uses liquid phase deposition technology for controlling deposit …
  • Orly International, Inc.:企業の戦略・SWOT・財務情報
    Orly International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Orly International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Inner Mongolia Yili Industrial Group Co Ltd
    Inner Mongolia Yili Industrial Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Inner Mongolia Yili Industrial Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆